Erisipelas
DOI:
https://doi.org/10.55606/detector.v1i3.2271Keywords:
Erysipelas, lymphangitisAbstract
Erysipelas is an infection of the nonnecrotic superficial skin accompanied by lymphangitis. This infection will cause a clinical picture in the form of well-defined erythematous plaques. Most cases of erysipelas are caused by bacteria, most often the normal skin flora such as Streptococcus bacteria but erysipelas can also be caused by S. aureus and group C or G Streptococcus. Erysipelas can occur at any age. Erysipelas is closely related to the patient’s physical condition and cellular immune status which underlies or facilitates the occurrence of infections, including chronic systemic diseases suffered by these patients, such as diabetes mellitus, immunocompromised states. The lower extremities are the most common predilection for erysipelas. Most erysipelas patients come for treatment with the main complaint of swelling, redness, and pain experienced by the patient accompanied by other complaints such as burning and itching which are predisposing factors to the occurrence of this infection. The diagnosis of erysipelas is based on anamnesis, physical examination and laboratory tests. The management of erysipelas is the administration of antibiotics and wound care.
References
Dalal A, Eskin-Schwartz M, Mimouni D, Ray S, Days W, Hodak E, et al. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database Syst Rev. 2017;6:CD009758.
Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215(2):118–22.
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
K W, L G, S K, AS P, Leffel D. Fitzpatrick’s Dermatology in General Medicine, 8th Edition. 8th ed. New York: McGraw-Hill; 2011. 184–187 p.
J. Concheiro, M. Loureiro, D. González-Vilas, J. García-Gavín. Erysipelas and Cellulitis: A Retrospective Study of 122 Cases. Actas Dermosifiliogr. 2009;100:888–94.
Meilia Novarina R. Profil Pasien Erisipelas dan Selulitis (The Profile of Erysipelas and Cellulitis Patients).
Stevens DL, Bryant AE. Impetigo, Erysipelas and Cellulitis. 2016.
Krasagakis K, Valachis A, Maniatakis P, Krüger-Krasagakis S, Samonis G, Tosca AD. Analysis of epidemiology, clinical features and management of erysipelas. Int J Dermatol. 2010 Sep;49(9):1012–7.
Meilia Novarina R. Profil Pasien Erisipelas dan Selulitis (The Profile of Erysipelas and Cellulitis Patients).
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014 Jul 15;59(2):e10-52.
Veraldi S, Girgenti V, Dassoni F, Gianotti R. Erysipeloid: a review. Clin Exp Dermatol. 2009 Dec;34(8):859–62.
Puvanendran R, Huey JCM, Pasupathy S. Necrotizing fasciitis. Can Fam Physician. 2009 Oct;55(10):981–7.
Mehta J, Rolta R, Mehta BB, Kaushik N, Choi EH, Kaushik NK. Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review. Front Microbiol. 2022;13:813358.
Hidayat AN, Damayanti, Sari M, Widia Y. Infeksi Bakteri di Kulit. Surabaya: Airlangga University Press; 2019. 58–60 p
